Imagion Biosystems Limited (ASX:IBX)

Imagion Biosystems Revenue

Imagion Biosystems had revenue of 525.93K AUD in the half year ending June 30, 2026, a decrease of -67.83%. This brings the company's total for the last twelve months to 573.23K, down -45.71% year-over-year. In the year 2025, Imagion Biosystems had annual revenue of 73.03K, down -97.26%. That makes Imagion Biosystems the 44,824th largest company in the world by revenue and 1,065th in Australia.

• Revenue (ttm): 573.23K
• Revenue Growth: -45.71%
• P/S Ratio: 5.18
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.97M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Australia 1.46M 54.7%
• United States of America 1.21M 45.3%

Fiscal year ended Dec 31, 2024 See the full Imagion Biosystems breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.03K	-2.59M	-97.26%
Dec 31, 2024	2.67M	-2.31M	-46.38%
Dec 31, 2023	4.97M	1.90M	61.87%
Dec 31, 2022	3.07M	215.36K	7.54%
Dec 31, 2021	2.86M	158.60K	5.88%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 6, 2026

Data Sources Report a data error